Study of Gefapixant (MK-7264) in Acute Cough for Participants With Induced Viral Upper Respiratory Tract Infection (URTI) (MK-7264-013)

Inclusion Criteria: * In good general health * Susceptible to human rhinovirus type 16 (HRV-16) * Male or non-pregnant and non-breast feeding female * If female of reproductive potential, agrees to use 1 form of acceptable birth control Exclusion Criteria: * Donated blood within 56 days or donated plasma within 7 days prior to dosing * History of significant multiple and/or severe allergies * Recent history of respiratory tract infection * History of cancer * Body mass index \<18 kg/m\^2 or ≥40 kg/m\^2 * History of major surgery or loss of 1 unit of blood * History of allergic reaction to sulfonamides * Received medications within 14 days prior to randomization * Significantly abnormal laboratory tests at Screening * Current smoker, smoked within 5 years of Screening, or significant past smoking history * History of alcohol or drug abuse